Revenue: The sum of all revenue fields included for a company's operating activities.
Intellia Therapeutics, Inc. (NTLA) had Revenue of $23.02M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$23.02M |
$-95.79M |
|
-- |
|
$23.02M |
|
$121.73M |
|
$-98.71M |
|
$2.92M |
|
$-95.79M |
|
$-95.79M |
|
$-95.79M |
|
$-95.79M |
|
$-95.79M |
|
$-95.79M |
|
$-98.71M |
|
$-92.69M |
|
108.38M |
|
108.38M |
|
$-0.81 |
|
$-0.81 |
|
| Balance Sheet Financials | |
$527.71M |
|
$17.67M |
|
$314.42M |
|
$842.13M |
|
$103.88M |
|
-- |
|
$66.85M |
|
$170.73M |
|
$671.39M |
|
$671.39M |
|
$671.39M |
|
116.32M |
|
| Cash Flow Statement Financials | |
$-394.74M |
|
$228.03M |
|
$131.49M |
|
$202.79M |
|
$167.57M |
|
$-35.22M |
|
$80.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-428.86% |
|
-428.86% |
|
-- |
|
-416.15% |
|
-416.15% |
|
$-395.87M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
2.43 |
|
37.02 |
|
-14.27% |
|
-14.27% |
|
-11.37% |
|
-14.27% |
|
$5.77 |
|
$-3.65 |
|
$-3.64 |
|